This episode, Professor Gino Martini is joined by representatives from Kindeva Drug Delivery. 

Kindeva develops and manufactures complex drug device combination products, with a focus on transdermal and inhalation drug delivery products.

Gino welcomes Laura Walsh from Global Buisness Development, Dr. John Vasilakos, Global Head of MTS at Kindeva, and Lisa Dick, the leading platform scientist for microneedles. 

Kindeva originated as Riker Labatories, who invented the first metered-dose inhaler in 1956, before becoming pat of 3M.

Now, Laura, John and Lisa talk about Kindeva's microneedle technology, the impact of COVID-19, and other technologies. 

Hosted on Acast. See acast.com/privacy for more information.